Independent clinical and operational assessment to establish the regulatory risk that determines asset value, transaction viability, and post-acquisition exposure.
Latent liabilities that are not visible through financial audit alone are identified, establishing the operational reality behind the balance sheet.
All engagements are led by senior leadership — Roxana Rosca (Clinical Strategy), Emerson Kupfuwa (Operational Recovery), and Dr Sundeep Kaul PhD (Quality Governance & Systems).
Professional Workstreams
Regulatory Due Diligence (M&A & Private Equity)
Focus: Transaction risk, asset valuation, and registration continuity.
Liability Mapping: Establishing the regulatory standing of a target asset, identifying liabilities that may transfer to incoming operators, open conditions, and enforcement patterns beneath the surface of the accounts.
Governance & Leadership Liability: Assessment of leadership stability and governance systems — primary indicators of post-acquisition regulatory intervention.
Remediation Costing: Quantifying the capital required for regulatory recovery prior to completion, ensuring pricing reflects the true cost of compliance.
This enables informed decisions on acquisition viability, pricing adjustment, and downside risk exposure.
Insolvency & Restructuring
Focus: Asset protection and disposal viability.
Baseline at Appointment: Immediate regulatory baseline assessment upon appointment of an Insolvency Practitioner, establishing a clear baseline of risk and compliance exposure to inform administration strategy.
Mitigating Value Erosion: Identification of operational failures driving regulatory risk, ensuring the asset remains viable and saleable throughout the restructuring process.
Registration Continuity: Regulatory transition during disposal is managed to protect the asset from the immediate value collapse associated with loss, restriction, or instability of registration.
Portfolio & Lender Risk Assessment
Focus: Ongoing monitoring and value protection.
Regulatory Health Checks: Periodic independent assessments of regulated assets within a portfolio to identify emerging risks before formal regulatory intervention materially impacts asset value.
Early Warning Analysis: The leading indicators of clinical and operational failure are identified before regulatory intervention, allowing lenders and investors to act while asset value remains protectable.
Distressed Asset & Turnaround
Focus: Urgent stabilisation, enforcement mitigation, and recovery.
48-Hour Forensic Assessment: Immediate deployment to establish the true condition of a distressed asset, providing an objective picture of clinical, operational, and governance risk.
Stabilisation & Evidential Baselines: Director-level on-site leadership to stabilise failing services and build the contemporaneous evidential record required to mitigate enforcement and protect registration.
The Director-Led Guarantee
Every workstream is directly managed by Roxana Rosca or Emerson Kupfuwa. Regulatory assessment and site stabilisation are not delegated to junior consultants.